Authors:
Ranke, MB
Lindberg, A
Chatelain, P
Wilton, P
Price, DA
Albertsson-Wikland, K
Citation: Mb. Ranke et al., The potential of prediction models based on data from KIGS as tools to measure responsiveness to growth hormone, HORMONE RES, 55, 2001, pp. 44-48
Authors:
Faivre, L
Le Merrer, M
Baumann, C
Polak, M
Chatelain, P
Sulmont, V
Cousin, J
Bost, M
Cordier, MP
Zackai, E
Russell, K
Finidori, G
Pouliquen, JC
Munnich, A
Maroteaux, P
Cormier-Daire, V
Citation: L. Faivre et al., Acromicric dysplasia: long term outcome and evidence of autosomal dominantinheritance, J MED GENET, 38(11), 2001, pp. 745-749
Authors:
Cutfield, WS
Wilton, P
Bennmarker, H
Albertsson-Wikland, K
Chatelain, P
Ranke, MB
Price, DA
Citation: Ws. Cutfield et al., Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment, LANCET, 355(9204), 2000, pp. 610-613
Authors:
de Zegher, F
Albertsson-Wikland, K
Wollmann, HA
Chatelain, P
Chaussain, JL
Lofstrom, A
Jonsson, B
Rosenfeld, RG
Citation: F. De Zegher et al., Growth hormone treatment of short children born small for gestational age:Growth responses with continuous and discontinuous regimens over 6 years, J CLIN END, 85(8), 2000, pp. 2816-2821
Authors:
Ranke, MB
Lindberg, A
Chatelain, P
Wilton, P
Cutfield, W
Albertsson-Wikland, K
Price, DA
Citation: Mb. Ranke et al., Prediction of long-term response to recombinant human growth hormone in Turner syndrome: Development and validation of mathematical models, J CLIN END, 85(11), 2000, pp. 4212-4218
Citation: H. Sunthorn et al., Paroxysmal atrioventricular block during coronary revascularisation with ultrasound: a case report, ARCH MAL C, 93(9), 2000, pp. 1151-1154
Authors:
Vallee, JP
Lazeyras, F
Kasuboski, L
Chatelain, P
Howarth, N
Righetti, A
Didier, D
Citation: Jp. Vallee et al., Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function, J MAGN R I, 9(2), 1999, pp. 197-203
Authors:
Stagnara, J
Chatelain, P
David, T
Floret, D
Duquesne, A
Durr, F
Citation: J. Stagnara et al., Public health network for medico-surgical pediatric emergencies in the Lyons Urban Community, ARCH PED, 6, 1999, pp. 482S-484S
Authors:
Wacinski, P
Urban, P
Chatelain, P
Bacchiocchi-Suilen, C
De Olival, JR
Dorsaz, PA
Citation: P. Wacinski et al., Complete myocardial revascularization by single session triple vessel percutaneous coronary angioplasty and provisional stenting, J INTERV CA, 12(5), 1999, pp. 349-353
Authors:
Ranke, MB
Lindberg, A
Chatelain, P
Wilton, P
Cutfield, W
Albertsson-Wikland, K
Price, DA
Citation: Mb. Ranke et al., Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models, ACT PAEDIAT, 88, 1999, pp. 122-125
Authors:
Ranke, MB
Savage, MO
Chatelain, P
Preece, MA
Rosenfeld, RG
Wilton, P
Citation: Mb. Ranke et al., Treatment of growth hormone insensitivity syndrome with insulin-like growth factor I: long-term results of the European multicentre study, ACT PAEDIAT, 88, 1999, pp. 180-180
Authors:
Savage, M
Rosenfeld, R
Underwood, L
Chatelain, P
Guevara-Aguirre, J
Clayton, P
Citation: M. Savage et al., Serum levels of insulin-like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity - Discussion, ACT PAEDIAT, 88, 1999, pp. 192-192
Authors:
Juul, A
Bernasconi, S
Chatelain, P
Hindmarsh, P
Hochberg, Z
Hokken-Koelega, A
Keizer-Schrama, SMPFD
Kiess, W
Oberfield, S
Parks, J
Strasburger, CJ
Volta, C
Westphal, O
Skakkebaek, NE
Citation: A. Juul et al., Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders, HORMONE RES, 51(6), 1999, pp. 284-299
Authors:
Ranke, MB
Lindberg, A
Chatelain, P
Wilton, P
Cutfield, W
Albertsson-Wikland, K
Price, DA
Citation: Mb. Ranke et al., Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency, J CLIN END, 84(4), 1999, pp. 1174-1183
Authors:
Rey, RA
Belville, C
Nihoul-Fekete, C
Michel-Calemard, L
Forest, MG
Lahlou, N
Jaubert, F
Mowszowicz, I
David, M
Saka, N
Bouvattier, C
Bertrand, AM
Lecointre, C
Soskin, S
Cabrol, S
Crosnier, H
Leger, J
Lortat-Jacob, S
Nicolino, M
Rabl, W
Toledo, SPA
Bas, F
Gompel, A
Czernichow, P
Chatelain, P
Rappaport, R
Morel, Y
Josso, N
Citation: Ra. Rey et al., Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement, J CLIN END, 84(2), 1999, pp. 627-631
Citation: Jp. Monson et P. Chatelain, How should we transfer patients from paediatric to adult clinics?, CHALLENGES IN GROWTH HORMONE THERAPY, 1999, pp. 222-231
Authors:
Bozzola, M
Zecca, M
Locatelli, F
Radetti, G
Pagani, S
Autelli, M
Tato, L
Chatelain, P
Citation: M. Bozzola et al., Evaluation of growth hormone bioactivity using the Nb-2 cell bioassay in children with growth disorders, J ENDOC INV, 21(11), 1998, pp. 765-770